Interactions of mutant p53 with DNA: guilt by association

被引:30
作者
Kim, E.
Deppert, W.
机构
[1] Univ Gottingen, Dept Neurosurg, Translat Neurooncol Grp, D-37075 Gottingen, Germany
[2] Heinrich Pette Inst, Hamburg, Germany
关键词
mutant p53; DNA binding; chromatin interaction; non-B DNA; transcription;
D O I
10.1038/sj.onc.1210312
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since the very early days of p53 research, the gain of oncogenic activities by some mutant p53 proteins had been suspected as an important factor contributing to cancer progression. Considerable progress towards understanding the biology of mutant p53 has been made during the last years, the quintessence being the realization that the impact of mutant p53 proteins on the transcriptome of a tumor cell is much more global than previously thought. The emerging role of mutant p53 proteins in coordinating oncogenic signaling and chromatin modifying activities reveals an until now unsuspected function of these proteins as important modifiers of the oncogenic transcriptional response. Notwithstanding the fact that the sequence specific DNA binding activity of mutant p53 proteins is impaired, they are still able to associate with specific loci on DNA by utilizing different mechanisms. The ability to associate with DNA appears to be crucial for the master role of mutant p53 proteins in coordinating oncogenic transcriptional responses.
引用
收藏
页码:2185 / 2190
页数:6
相关论文
共 48 条
  • [1] The C-terminus of p53: the more you learn the less you know
    Ahn, J
    Prives, C
    [J]. NATURE STRUCTURAL BIOLOGY, 2001, 8 (09) : 730 - 732
  • [2] Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains
    Ang, Hwee Ching
    Joerger, Andreas C.
    Mayer, Sebastian
    Fersht, Alan R.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (31) : 21934 - 21941
  • [3] p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease
    Bae, BI
    Xu, H
    Igarashi, S
    Fujimuro, M
    Agrawal, N
    Taya, Y
    Hayward, SD
    Moran, TH
    Montell, C
    Ross, CA
    Snyder, SH
    Sawa, A
    [J]. NEURON, 2005, 47 (01) : 29 - 41
  • [4] p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements
    Campomenosi, P
    Monti, P
    Aprile, A
    Abbondandolo, A
    Frebourg, T
    Gold, B
    Crook, T
    Inga, A
    Resnick, MA
    Iggo, R
    Fronza, G
    [J]. ONCOGENE, 2001, 20 (27) : 3573 - 3579
  • [5] Mutant p53 forms a complex with Sp1 on HIV-LTR DNA
    Chicas, A
    Molina, P
    Bargonetti, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) : 383 - 390
  • [6] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
    CHO, YJ
    GORINA, S
    JEFFREY, PD
    PAVLETICH, NP
    [J]. SCIENCE, 1994, 265 (5170) : 346 - 355
  • [7] Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
    Di Agostino, Silvia
    Strano, Sabrina
    Emiliozzi, Velia
    Zerbini, Valentina
    Mottolese, Farcella
    Sacchi, Ada
    Blandino, Giovanni
    Piaggio, Giulia
    [J]. CANCER CELL, 2006, 10 (03) : 191 - 202
  • [8] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [9] p53 tumor suppressor protein regulates the levels of huntingtin gene expression
    Feng, Z
    Jin, S
    Zupnick, A
    Hoh, J
    de Stanchina, E
    Lowe, S
    Prives, C
    Levine, AJ
    [J]. ONCOGENE, 2006, 25 (01) : 1 - 7
  • [10] Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain
    Frazier, MW
    He, XP
    Wang, JL
    Gu, ZM
    Cleveland, JL
    Zambetti, GP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) : 3735 - 3743